Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant (Q40441867)

20 September 2017

title

Prolonged anorexia and elevated plasma cytokine levels following myeloablative allogeneic hematopoietic cell transplant (English)

1 reference

20 September 2017

2

W M Leisenring

1 reference

20 September 2017

F R Malone

1

1 reference

20 September 2017

B E Storer

3

1 reference

20 September 2017

R Lawler

4

1 reference

20 September 2017

J M Stern

5

1 reference

20 September 2017

S N Aker

6

1 reference

20 September 2017

M E Bouvier

7

1 reference

20 September 2017

P J Martin

8

1 reference

20 September 2017

A L Batchelder

9

1 reference

20 September 2017

H G Schoch

10

1 reference

20 September 2017

G B McDonald

11

1 reference

20 September 2017

language of work or name

English

0 references

publication date

13 August 2007

1 reference

Bone Marrow Transplantation

20 September 2017

published in

1 reference

20 September 2017

volume

40

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

765-772

1 reference

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Energy expenditure of acutely ill hospitalised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Tumor necrosis factor-alpha gene transfer induces cachexia and inhibits muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Systemic Interleukin-1beta stimulates the simultaneous release of norepinephrine in the paraventricular nucleus and the median eminence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Cancer anorexia-cachexia syndrome: cytokines and neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

The Smad3 Protein Is Involved in TGF- Inhibition of Class II Transactivator and Class II MHC Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Advances in biologic therapy for ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Cytokine signal transduction through a homo- or heterodimer of gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Risk Factors for Anaerobic Bloodstream Infections in Bone Marrow Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Nutrient support in hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Body composition changes in marrow transplant recipients receiving total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Parenteral nutrition support after bone marrow transplantation: comparison of total and partial parenteral nutrition during the early posttransplantation period

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Nutritional support in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

trans fatty acids and systemic inflammation in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Gut barrier function in malnourished patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Intestinal cytokine response after gut ischemia: role of gut barrier failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Plasma cytokines in graft vs host disease and complications following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705816

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705816

1 reference

Dimensions Publication ID

20 September 2017

1000013812

0 references

1 reference